Japanese government

The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.

The Japan Times says regulations are needed to oversee human genome-editing research.

Got to Get Ahead

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.

The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.